These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19768401)

  • 1. Generation and characterization of candidate vaccine viruses for prepandemic influenza vaccines.
    O'Neill E; Donis RO
    Curr Top Microbiol Immunol; 2009; 333():83-108. PubMed ID: 19768401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
    Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
    ; Ampofo WK; Baylor N; Cobey S; Cox NJ; Daves S; Edwards S; Ferguson N; Grohmann G; Hay A; Katz J; Kullabutr K; Lambert L; Levandowski R; Mishra AC; Monto A; Siqueira M; Tashiro M; Waddell AL; Wairagkar N; Wood J; Zambon M; Zhang W
    Influenza Other Respir Viruses; 2012 Mar; 6(2):142-52, e1-5. PubMed ID: 21819547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated vaccines for pandemic influenza.
    Chen GL; Subbarao K
    Curr Top Microbiol Immunol; 2009; 333():109-32. PubMed ID: 19768402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status and progress of prepandemic and pandemic influenza vaccine development.
    Leroux-Roels I; Leroux-Roels G
    Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against influenza: role and limitations in pandemic intervention plans.
    Rebmann T; Zelicoff A
    Expert Rev Vaccines; 2012 Aug; 11(8):1009-19. PubMed ID: 23002981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus surveillance, vaccine strain selection, and manufacture.
    Stöhr K; Bucher D; Colgate T; Wood J
    Methods Mol Biol; 2012; 865():147-62. PubMed ID: 22528158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.
    Ampofo WK; Azziz-Baumgartner E; Bashir U; Cox NJ; Fasce R; Giovanni M; Grohmann G; Huang S; Katz J; Mironenko A; Mokhtari-Azad T; Sasono PM; Rahman M; Sawanpanyalert P; Siqueira M; Waddell AL; Waiboci L; Wood J; Zhang W; Ziegler T;
    Vaccine; 2015 Aug; 33(36):4368-82. PubMed ID: 26148877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens.
    Strecker T; Uhlendorff J; Diederich S; Lenz-Bauer C; Trusheim H; Roth B; Kolesnikova L; Aepinus C; Dornow R; Gerlach J; Matrosovich M; Valley U; Eickmann M; Becker S
    Clin Chem Lab Med; 2012 May; 50(7):1275-9. PubMed ID: 22850059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of pilot lots of inactivated influenza vaccine in response to a pandemic threat: an interim biosafety risk assessment.
    Wkly Epidemiol Rec; 2003 Nov; 78(47):405-8. PubMed ID: 14677515
    [No Abstract]   [Full Text] [Related]  

  • 11. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.
    Wood JM; Robertson JS
    Nat Rev Microbiol; 2004 Oct; 2(10):842-7. PubMed ID: 15378048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges.
    Hessel L;
    Influenza Other Respir Viruses; 2009 Jul; 3(4):165-70. PubMed ID: 19627373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines for pandemic influenza.
    Luke CJ; Subbarao K
    Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pandemic influenza and the global vaccine supply.
    Fedson DS
    Clin Infect Dis; 2003 Jun; 36(12):1552-61. PubMed ID: 12802755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation.
    Shcherbik S; Pearce N; Balish A; Jones J; Thor S; Davis CT; Pearce M; Tumpey T; Cureton D; Chen LM; Villanueva J; Bousse TL
    PLoS One; 2015; 10(9):e0138951. PubMed ID: 26405798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference viruses for seasonal and pandemic influenza vaccine preparation.
    Wood JS; Robertson JS
    Influenza Other Respir Viruses; 2007 Jan; 1(1):5-9. PubMed ID: 19459278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza vaccines: the good, the bad, and the eggs.
    Schultz-Cherry S; Jones JC
    Adv Virus Res; 2010; 77():63-84. PubMed ID: 20951870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza pandemic preparedness action plan for the United States: 2002 update.
    Strikas RA; Wallace GS; Myers MG
    Clin Infect Dis; 2002 Sep; 35(5):590-6. PubMed ID: 12173135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis].
    Machała MK; Brydak LB
    Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of influenza vaccine strains and developing pandemic vaccines.
    Wood JM
    Vaccine; 2002 Dec; 20 Suppl 5():B40-4. PubMed ID: 12477418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.